Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
Kiniksa Pharmaceuticals (Nasdaq: KNSA) has announced its participation in two major investor conferences in June 2025. The company will present at the Jefferies 2025 Global Healthcare Conference on June 5 at 12:50 p.m. ET and participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on June 10 at 8:00 a.m. ET. Both presentations will be available via live webcast through Kiniksa's website in the Investors & Media section, with replays accessible within 48 hours after each event.
[]Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025. L'azienda presenter脿 al Jefferies 2025 Global Healthcare Conference il 5 giugno alle 12:50 ET e parteciper脿 a un incontro informale al Goldman Sachs 46th Annual Global Healthcare Conference il 10 giugno alle 8:00 ET. Entrambe le presentazioni saranno disponibili in diretta streaming sul sito web di Kiniksa nella sezione Investitori & Media, con le registrazioni accessibili entro 48 ore dalla fine di ciascun evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha anunciado su participaci贸n en dos importantes conferencias para inversores en junio de 2025. La compa帽铆a presentar谩 en la Jefferies 2025 Global Healthcare Conference el 5 de junio a las 12:50 p.m. ET y participar谩 en una charla informal en la Goldman Sachs 46th Annual Global Healthcare Conference el 10 de junio a las 8:00 a.m. ET. Ambas presentaciones estar谩n disponibles en transmisi贸n en vivo a trav茅s del sitio web de Kiniksa en la secci贸n de Inversores y Medios, con repeticiones accesibles dentro de las 48 horas posteriores a cada evento.
Kiniksa Pharmaceuticals (雮橃姢雼�: KNSA)電� 2025雲� 6鞗� 霊� 臧滌潣 欤检殧 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 6鞗� 5鞚� 鞓ろ泟 12鞁� 50攵�(霃欕秬鞁滉皠) Jefferies 2025 Global Healthcare Conference鞐愳劀 氚滍憸頃橂┌, 6鞗� 10鞚� 鞓れ爠 8鞁�(霃欕秬鞁滉皠) Goldman Sachs 46th Annual Global Healthcare Conference鞐愳劀 韺岇澊鞏挫偓鞚措摐 毂勴寘鞐� 彀胳棳頃� 鞓堨爼鞛呺媹雼�. 霊� 氚滍憸 氇憪 Kiniksa 鞗轨偓鞚错姼鞚� 韴瀽鞛� 氚� 氙鸽敂鞏� 靹轨厴鞚� 韱淀暣 靸濎瓿勲悩氅�, 臧� 頄夓偓 膦呺 頉� 48鞁滉皠 鞚措偞鞐� 雼れ嫓氤搓赴臧� 臧�電ロ暕雼堧嫟.
Kiniksa Pharmaceuticals (Nasdaq : KNSA) a annonc茅 sa participation 脿 deux grandes conf茅rences pour investisseurs en juin 2025. La soci茅t茅 pr茅sentera lors de la Jefferies 2025 Global Healthcare Conference le 5 juin 脿 12h50 ET et participera 脿 une discussion informelle lors de la Goldman Sachs 46th Annual Global Healthcare Conference le 10 juin 脿 8h00 ET. Les deux pr茅sentations seront disponibles en direct via le site web de Kiniksa dans la section Investisseurs & M茅dias, avec des rediffusions accessibles dans les 48 heures suivant chaque 茅v茅nement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im Juni 2025 angek眉ndigt. Das Unternehmen wird am Jefferies 2025 Global Healthcare Conference am 5. Juni um 12:50 Uhr ET pr盲sentieren und an einem Fireside-Chat auf der Goldman Sachs 46th Annual Global Healthcare Conference am 10. Juni um 8:00 Uhr ET teilnehmen. Beide Pr盲sentationen werden live 眉ber die Website von Kiniksa im Bereich Investoren & Medien 眉bertragen, mit Wiedergaben, die innerhalb von 48 Stunden nach jeder Veranstaltung verf眉gbar sind.
- None.
- None.
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- 听(狈补蝉诲补辩: KNSA) today announced that management will present at the following investor conferences in June:
- Jefferies 2025 Global Healthcare Conference on Thursday, June 5 at 12:50 p.m. Eastern Time
- Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10 at 8:00 a.m. Eastern Time 鈥� Fireside Chat
A live webcast of Kiniksa鈥檚 presentations will be accessible through the Investors & Media section of the company鈥檚 website at . A replay of the events will also be available on Kiniksa鈥檚 website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa鈥檚 portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit聽.
Every Second Counts! 庐
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
FAQ
When is Kiniksa Pharmaceuticals (KNSA) presenting at the Jefferies Healthcare Conference 2025?
What time is KNSA's presentation at the Goldman Sachs Healthcare Conference 2025?
How can I access Kiniksa Pharmaceuticals' investor conference presentations?
Which investor conferences is KNSA attending in June 2025?
